Company intelligence / Profile preview
Immunofoco
Shanghai, Shanghai, Chinaimmunofoco.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Immunofoco is a clinical-stage biotech company developing innovative immune cell therapies for solid tumors. Its lead program IMC001 has shown a favorable safety profile with a disease control rate of 90% in early trials; IMC002 has received Orphan Drug Designation from the FDA and IND approvals in both China and the US. The company’s pipeline leverages proprietary platforms to address tumor heterogeneity and improve efficacy/safety of cell therapy products.
- Therapeutic areas
- Oncology
- Modalities
- CAR-T cell therapies (Chimeric Antigen Receptor T-cell therapies)In vivo CAR-T platforms using lentiviral technologyRNAi-based therapeutics (Peri Cruiser® platform)
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
03
Partnerships
Collaborations with clinical organizations, hospitals, research institutesScience & Technology Commission of Shanghai (funded by)Chengdu Capital Group (investor)
Beyond the preview
Go deeper on Immunofoco.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunofoco.